Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fibroblast growth factor 7 pseudogene 2 is a genomic DNA sequence classified as a pseudogene, related by sequence similarity to the functional gene "Fibroblast growth factor 7" (FGF7). It is located on chromosome 21 and annotated by HGNC and Ensembl as a pseudogene and also known by the synonym FGF7L. Pseudogenes like FGF7P2 typically do not produce functional proteins or have direct biological functions, do not participate in disease mechanisms, and are not considered therapeutic targets. There is no evidence or annotation indicating that FGF7P2 is a receptor, enzyme, transporter, or directly implicated in drug interactions, biomarker roles, or safety concerns. It is sometimes listed with alternative names such as FGF7L and PRED3, but these are not associated with functional biological activity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fibroblast growth factor 7 pseudogene 2 (FGF7P2).